For decades, expecting mothers have been considered a vulnerable group, for the potential harm to their fetuses’ health.
This comes months after the President of Madagascar promotes a drink based on Artemisia, a plant with proven efficacy in malaria treatment, was met with widespread scorn.
RDIF, Dr Reddy's Lab tie up for Sputnik V human trials, distribution of 100 mn doses of the COVID-19 vaccine in India
As of 1 August, Phase I and II of the vaccine were complete and by 11 August, Russian President Vladimir Putin had registered it as the world's first vaccine.
UAE announces emergency use of COVID-19 vaccine that is still in its final testing, for healthcare workers
Chinese drug giant Sinopharm began the third phase of trials for a Covid-19 vaccine in the UAE in July, with Emirati officials saying the results have been positive.
The vaccine is given in two doses and will help people develop immunity to the virus for at least two years.
The director of AIIMS Delhi said 'If Russia’s vaccine is successful, then we will have to see critically whether it is safe and effective.'
The Gamaleya Institute developed the Russian vaccine using a human cell line first cultured in 1973 — the same line used in the Oxford-AstraZeneca vaccine.
This final leg of human vaccine trials will recruit 5,000 volunteers above age 18 in Riyadh, Dammam and Mecca.
Hydroxychloroquine, dexamethasone, remdesivir: Studies offer proof of which COVID-19 drugs really work
Sixty percent of patients given HCQ were less likely to leave the hospital alive within 28 days versus the 63 percent given usual care.
Human challenge trials have been used to test other vaccines but there were rescue medicines to cure those who got sick. There is no cure for COVID-19.
Oxford's vaccine offers ‘good duration of immunity’ to COVID-19 compared to no vaccine: lead researcher
The vaccine has been licensed to AstraZeneca and is in its Phase III of its human trials in the UK.
China allows limited use of COVID-19 vaccine CanSino for their military after clinical trials shows its effectiveness
The vaccine has been approved for a period of one year after clinical trials proved it was safe and showed some efficacy.
First COVID-19 vaccine to enter human trials is safe, well-tolerated and able to generate immune response against virus
The trial was carried out in 108 healthy adults with the vaccine demonstrating promising results after 28 days.
The preliminary findings, in the first eight people, must be repeated in thousands of people, to find out if the vaccine works in the real world.
Coronavirus India Roundup, May 5: Highest increase in cases and deaths in the last 24 hours, death toll reaches 1,583
India observed the highest increase in the number of confirmed cases and deaths in the last 24 hours, with 3,900 new cases and 195 patients passing away.
Gilead rubbishes claim that antiviral drug, Remdesivir, failed to help Coronavirus patients in Chinese trial
Doctors suggest antiviral drugs would be most effective when administered as early as possible as it helps keep the virus from replicating in the blood.
Coronavirus Outbreak: Leaked results of a clinical trial hints Gliead's Remdesivir could be possible COVID-19 cure
During the trial, 113 patients were treated with the drug, most were discharged from the hospital in under a week, and only two died.
They are waiting on the final approvals but are recruiting volunteers, taking blood tests, and explaining the process while checking their health status.
Initial study of remdesivir, an antiviral drug, shows that two-thirds of severe COVID-19 patients got better
For now, Remdesivir is available for compassionate use, meaning that doctors can request the drug if a patient is in a dire situation with no alternatives.
Potential COVID-19 vaccines: From a self-limiting virus to a self-assembling vaccine, scientists are pulling out all the stops
There is currently no authorized treatment for the infection, though various governments have green-lighted emergency treatments with little evidence.